We serve Chemical Name:5-Amino-2-nitrobenzotrifluoride CAS:393-11-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Amino-2-nitrobenzotrifluoride
CAS.NO:393-11-3
Synonyms:4-Nitro-α,α,α-trifluoro-m-toluidine;4-Nitro-3-(trifluormethyl)aniline;WNR DZ BXFFF;3-trifluoromethyl-4-nitroaniune;2-NITRO-5-AMINO BENZOTRIFLUORIDE;5-Amino-2-nitrobenzotrifluoride;4-Nitro-3-(trifluoromethyl)benzenamine;Benzenamine, 4-nitro-3-(trifluoromethyl)-;EINECS 206-884-6;FLU-1;MFCD00014717;3-AMINO-6-NITROBENZOTRIFLUORIDE;4-Nitro-3-trifluoromethylaniline;4-Nitro-3-aminobenzotrifluoride;3-trifluoromethyl-4-nitroanilide;4-Nitro-3-(trifluoromethyl)aniline;3-Trifluoromethyl-4-nitroaniline
Molecular Formula:C7H5F3N2O2
Molecular Weight:206.122
HS Code:2921420090
Physical and Chemical Properties:
Melting point:125-129 °C(lit.)
Boiling point:326.4±42.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.525
PSA:71.84000
Exact Mass:206.030319
LogP:2.90
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN2811
Packing Group:III
Contact us for information like 4-Nitro-α,α,α-trifluoro-m-toluidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Trifluoromethyl-4-nitroaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,FLU-1 Use and application,3-trifluoromethyl-4-nitroanilide technical grade,usp/ep/jp grade.
Related News: Charles River looks forward to continuing its ongoing partnership with AstraZeneca. It was great to join the team today, to see the facility for myself and congratulate them on this really significant expansion, which will see an €8m investment, creating 90 new jobs for Mayo. rhodium,thulium manufacturers A number of drugmakers are also developing inhaled treatments for COVID-19, including Verona Pharma. (S)-2-{2-[2-(2,6-Dichloro-phenylamino)-phenyl]-acetylamino}-3-(1H-indol-3-yl)-propionic acid methyl ester suppliers AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. rhodium,terbium vendor & factory.
